Oncology

Comprehensive Summary

This study uses deep-learning AI models to develop an unrestricted, computer-vision based approach that targets objective breast density in mastography screenings, focusing on convenience, reliability, and pertinence in underrepresented healthcare settings. The researchers implemented a custom-designed convolutional neural network (CD-CNN) and extreme learning machine (ELM) for image-based breast density classification purposes. The chosen dataset consisted of 10,372 full-field mammograms that were pre-classified by radiologists into one of the four Breast Imaging Reporting and Data System (BI-RADS) categories, from A through D. The 3 + ELM model, deemed to be the most promising, successfully concluded with a testing accuracy (percentage of correct classifications) of 95.4%, specificity (amount of predicted positives that are actually positive) of 98.0%, and sensitivity (correctly predicted positives) of 92.5%, indicating a strong overlap between the conclusions of the model and the researchers — the recorded weighted kappa was 90%, with the true kappa value falling between 82% and 98% according to a 95% confidence interval (CI). The overall final testing accuracy, specificity, and sensitivity are as follows: 0.739 (95% CI: 0.692–0.787), 0.811 (95% CI: 0.769–0.853), and 0.751 (95% CI: 0.704–0.798) respectively. The study not only concluded that pre-trained models demonstrated lower efficiency, but also that the structure of the 3 + ELM model was best suited for this dataset.

Outcomes and Implications

When compared to current applications of AI, the 3 + ELM model’s strong performance and affordability make it a promising tool to aid breast density screenings in marginalized and underserved communities. This tool introduces the option of convenient and affordable density screenings for women in such environments, which in turn assist in breast-cancer risk assessments as mammography is considered a form of early detection screening. Overall, widespread implementation of the 3 + ELM model has the potential to bring accessible and cost-effective care to populations that typically do not have access to such methods of screening care.

Our mission is to

Connect medicine with AI innovation.

No spam. Only the latest AI breakthroughs, simplified and relevant to your field.

Our mission is to

Connect medicine with AI innovation.

No spam. Only the latest AI breakthroughs, simplified and relevant to your field.

Our mission is to

Connect medicine with AI innovation.

No spam. Only the latest AI breakthroughs, simplified and relevant to your field.

AIIM Research

Articles

© 2025 AIIM. Created by AIIM IT Team

AIIM Research

Articles

© 2025 AIIM. Created by AIIM IT Team

AIIM Research

Articles

© 2025 AIIM. Created by AIIM IT Team